Reports for TEVA-SUCRALFATE

Brand name

TEVA-SUCRALFATE

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02045702
Ingredients
SUCRALFATE
Ingredient Strength
1 G
ATC Code
A02BX
A02BX
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
TEVA-SUCRALFATE 500 Resolved 2021-12-17 2022-01-20 151468
TEVA-SUCRALFATE 100 Resolved 2022-01-27 2022-02-25 153727
TEVA-SUCRALFATE 100 Resolved 2022-06-09 2022-09-08 162303
TEVA-SUCRALFATE 500 Resolved 2023-02-16 2023-06-09 184934
TEVA-SUCRALFATE 500 Resolved 2023-06-16 2023-07-21 195039
TEVA-SUCRALFATE 100 Resolved 2023-06-16 2023-10-04 195055
TEVA-SUCRALFATE 500 Resolved 2023-07-27 2023-08-04 200210
TEVA-SUCRALFATE 500 Resolved 2023-08-17 2023-10-04 202228
TEVA-SUCRALFATE 500 Resolved 2023-12-14 2024-06-13 213368
TEVA-SUCRALFATE 100 Resolved 2024-03-07 2024-05-30 221540

Showing 11 to 20 of 23

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports
TEVA-SUCRALFATE ALL (100's and 500's) Discontinued 2025-09-02 2025-09-02 266359

Showing 1 to 1 of 1